Internal Server Error

NovoBind Livestock Therapeutics - About the company

NovoBind Livestock Therapeutics is a series A company based in Vancouver (Canada), founded in 2012 by Hamlet Abnousi, Slade Loutet, Filip Van Petegem and Sylvia Cheung. It operates as a Manufacturer and supplier of biological products for animal health protection. NovoBind Livestock Therapeutics has raised an undisclosed amount in funding from investors like Seventure Partners, Lallemand and The Center for Aquaculture Technologies. The company has 19 active competitors, including 4 funded and 1 that has exited. Its top competitors include companies like Benchmark Holdings, Carus Laboratories and Proteon Pharmaceuticals.

Company Details

Manufacturer and supplier of biological products for animal health protection. The company is developing next-generation biologics that target and neutralize the specific bacteria, viruses, and parasites that cause intestinal ailments in livestock, aquaculture, and pets.
Social
XFacebook
Email ID
*****@novobind.com
Registered Address
13 Mission Avenue, St. Albert
Key Metrics
Founded Year
2012
Location
Vancouver, Canada
Stage
Series A
Latest Funding Round
Ranked
Employee Count
11 as on Jul 01, 2024
Similar Companies
Sign up to download NovoBind Livestock Therapeutics' company profile

NovoBind Livestock Therapeutics's funding and investors

NovoBind Livestock Therapeutics has raised funding over 1 round. Its latest funding round was a Series A round on Feb 19, 2020 for $*****. 7 investors participated in its latest round. NovoBind Livestock Therapeutics has 10 institutional investors.

Here is the list of recent funding rounds of NovoBind Livestock Therapeutics:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Feb 19, 2020
3095658
Series A
3099181
2523066
9506988
6983174
lockAccess funding benchmarks and valuations. Sign up today!

NovoBind Livestock Therapeutics' founders and board of directors

Founder? Claim Profile
The founders of NovoBind Livestock Therapeutics are Hamlet Abnousi, Slade Loutet, Filip Van Petegem and Sylvia Cheung. Hamlet Abnousi is the CEO of NovoBind Livestock Therapeutics.
Here are the details of NovoBind Livestock Therapeutics' key team members:

NovoBind Livestock Therapeutics' Board of Directors

NovoBind Livestock Therapeutics's board has 5 active members. Hamlet Abnousi, Robert Allan Fraser, Donald Willoughby, Mitchell Abrahamsen and Nicholas Bedford are independent board members.
Here is the list of NovoBind Livestock Therapeutics' board of directors:
Name
Type
Representing
Status
Duration
Independent board member
-
Current
13y 5m
ghtjns{
Independent board member
-
Current
6y 9m
maycjyi
Independent board member
-
Current
4y 7m
vqior{s
Independent board member
-
Current
6y 1m
ilwcjel
Independent board member
-
Current
8y 7m

NovoBind Livestock Therapeutics' employee count trend

NovoBind Livestock Therapeutics has 11 employees as of Jul 24. Here is NovoBind Livestock Therapeutics's employee count trend over the years:
Employee count trend for NovoBind Livestock Therapeutics
lockUncover NovoBind Livestock Therapeutics' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

NovoBind Livestock Therapeutics's Competitors and alternates

Top competitors of NovoBind Livestock Therapeutics include Benchmark Holdings, Carus Laboratories and Proteon Pharmaceuticals. Here is the list of Top 10 competitors of NovoBind Livestock Therapeutics, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Benchmark Holdings
Benchmark Holdings
2000, Sheffield (United Kingdom), Public
Aquaculture biotechnology company
-
62/100
2nd
Logo for Carus Laboratories
Carus Laboratories
2006, Karnal (India), Unfunded
Provider of veterinary feed supplements
-
-
45/100
3rd
Logo for Proteon Pharmaceuticals
Proteon Pharmaceuticals
2005, Lodz (Poland), Series B
Developer of bacteriophage-based products for livestock farming and aquaculture health
$28.8M
43/100
4th
Logo for Peptobiotics
Peptobiotics
2021, Singapore (Singapore), Series A
Manufacturer of peptides-based livestock feed additives
$6.2M
42/100
5th
Logo for NovoBind Livestock Therapeutics
NovoBind Livestock Therapeutics
2012, Vancouver (Canada), Series A
Manufacturer and supplier of biological products for animal health protection
-
38/100
6th
Logo for Essential Aquatech
Essential Aquatech
2019, Jalpaiguri (India), Unfunded
Provider of health solutions for the aquaculture industry
-
-
31/100
7th
Provider of antibiotic detection and control solutions for livestock
-
28/100
8th
Logo for Maxx Performance
Maxx Performance
2004, Roanoke (United States), Unfunded
Provider of antibiotic substitutes for the treatment of various diseases in livestock animals
-
-
28/100
9th
Logo for PatoGen
PatoGen
2005, Alesund (Norway), Funding Raised
Provider of fish health services including detection, understanding, and action points
-
-
28/100
10th
Logo for AQUIT
AQUIT
2017, Vina del Mar (Chile), Unfunded
Provider of preventive treatment for infections in fish
-
-
24/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on NovoBind Livestock Therapeutics's competitors? Click here to see the top ones

NovoBind Livestock Therapeutics's Investments and acquisitions

NovoBind Livestock Therapeutics has made no investments or acquisitions yet.

Reports related to NovoBind Livestock Therapeutics

Here is the latest report on NovoBind Livestock Therapeutics's sector:

FAQs about NovoBind Livestock Therapeutics

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford